Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.49 |
| ▸ | GSR | P00390 | 1/20 | 0.44 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | GGT1 | P19440 | 1/20 | 0.40 |
| ▸ | CPB2 | Q96IY4 | 10/20 | 0.40 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | TLR2 | O60603 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2117551 | 1.00 | FOLH1 (0.49) | FOLH1GSRRNPEPMMP2MMP9 | |
| SCHEMBL433657 | 1.00 | FOLH1 (0.49) | FOLH1GSRRNPEPMMP2MMP9 | |
| SCHEMBL30540130 | 0.93 | FOLH1 (0.49) | FOLH1GSRRNPEPMMP2MMP9 | |
| SCHEMBL4087629 | 0.88 | FOLH1 (0.47) | FOLH1GSRRNPEPMMP2MMP9 | |
| SCHEMBL4100264 | 0.88 | FOLH1 (0.47) | FOLH1GSRRNPEPMMP2MMP9 | |
| Hydrochloric Acid SCHEMBL6010125 | 0.87 | FOLH1 (0.46) | FOLH1GSRRNPEPMMP2MMP9 | |
| Hydrochloric Acid SCHEMBL6010135 | 0.87 | FOLH1 (0.46) | FOLH1GSRRNPEPMMP2MMP9 | |
| SCHEMBL28450260 | 0.86 | SLC6A5 (0.52) | FOLH1SLC6A5TLR2 | |
| SCHEMBL9924207 | 0.85 | FOLH1 (0.45) | FOLH1GSRRNPEPMMP2MMP9 | |
| SCHEMBL6010377 | 0.83 | FOLH1 (0.41) | FOLH1GSRRNPEPMMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260043042-A1 | Plants with Modified Deoxyhypusine Synthase Genes | AGRIBODY TECHNOLOGIES, INC. (US) | 2026-02-12 | — | — | US | disclosed |
| US-20240366738-A1 | MOLECULAR VACCINES FOR INFECTIOUS DISEASE | AGILENT TECHNOLOGIES INC (US) | 2024-11-07 | — | — | US | disclosed |
| US-20240188521-A1 | Plants with Modified Deoxyhypusine Synthase Genes | AGRIBODY TECHNOLOGIES, INC. (US) | 2024-06-13 | — | — | US | disclosed |
| US-11992518-B2 | Molecular vaccines for infectious disease | AGILENT TECHNOLOGIES, INC. (US) | 2024-05-28 | — | — | US | disclosed |
| WO-2024011167-A2 | PLANTS WITH MODIFIED DEOXYHYPUSINE SYNTHASE GENES | AGRIBODY TECHNOLOGIES, INC. (US) | 2024-01-11 | — | — | WO | disclosed |
| US-10973187-B2 | Plants with modified deoxyhypusine synthase genes | AGRIBODY TECHNOLOGIES, INC. (US) | 2021-04-13 | — | — | US | disclosed |
| US-10968269-B1 | MHC multimers in borrelia diagnostics and disease | AGILENT TECHNOLOGIES, INC. (US) | 2021-04-06 | — | — | US | disclosed |
| US-20210047383-A1 | MHC Multimers in Borrelia Diagnostics and Disease | DAKO DENMARK APS (DK) | 2021-02-18 | — | — | US | disclosed |
| US-20200347103-A1 | MHC MULTIMERS IN TUBERCULOSIS DIAGNOSTICS, VACCINE AND THERAPEUTICS | AGILENT TECHNOLOGIES INC (US) | 2020-11-05 | — | — | US | disclosed |
| EP-3731626-A1 | PLANTS WITH MODIFIED DHS GENES | Agribody Technologies, Inc. (US) | 2020-11-04 | — | — | EP | disclosed |
| US-20030101488-A1 | DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants | SENESCO, INC. | 2003-05-29 | — | — | US | disclosed |
| US-6538182-B1 | Genetic modification of plants to control age-related or environmental stress-induced senescence; use in extending shelf-life and slowing spoilage of plant cuttings, flowers, seeds, fruits, vegatables, or leaves | SENESCO, INC. | 2003-03-25 | — | — | US | disclosed |
| WO-2003018014-A2 | METHODS OF INHIBITING FORMATION OF VASCULAR CHANNELS AND PROFILERATION USING PYRIDINONE DERIVATIVES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2003-03-06 | — | — | WO | disclosed |
| WO-2002044392-A2 | DNA ENCODING A PLANT DEOXYHYPUSINE SYNTHASE, A PLANT EUKARYOTIC INITIATION FACTOR 5A, TRANSGENIC PLANTS AND A METHOD FOR CONTROLLING SENESCENCE PROGRAMMED AND CELL DEATH IN PLANTS | SENESCO TECHNOLOGIES, INC. (US) | 2002-06-06 | — | — | WO | disclosed |
| EP-1200612-A2 | DNA ENCODING A PLANT DEOXYHYPUSINE SYNTHASE, A PLANT EUKARYOTIC INITIATION FACTOR 5A, TRANSGENIC PLANTS AND A METHOD FOR CONTROLLING SENESCENCE AND PROGRAMMED CELL DEATH IN PLANTS | Senesco, Inc. (US) | 2002-05-02 | — | — | EP | disclosed |
| WO-2001002592-A9 | DNA ENCODING A PLANT DEOXYHYPUSINE SYNTHASE, A PLANT EUKARYOTIC INITIATION FACTOR 5A, TRANSGENIC PLANTS AND A METHOD FOR CONTROLLING SENESCENCE AND PROGRAMMED CELL DEATH IN PLANTS | SENESCO INC (US) | 2001-08-02 | — | — | WO | disclosed |
| WO-2001002592-A2 | DNA ENCODING A PLANT DEOXYHYPUSINE SYNTHASE, A PLANT EUKARYOTIC INITIATION FACTOR 5A, TRANSGENIC PLANTS AND A METHOD FOR CONTROLLING SENESCENCE AND PROGRAMMED CELL DEATH IN PLANTS | SENESCO, INC. (US) | 2001-01-11 | — | — | WO | disclosed |
| US-5670477-A | Method to enhance permeability of the blood/brain blood/nerve bariers to therapeutic agents | Poduslo, Joseph F. (US) | 1997-09-23 | — | — | US | disclosed |
| WO-1994015596-A1 | COMPOSITIONS AND METHODS FOR INHIBITING DEOXYHYPUSINE SYNTHASE AND THE GROWTH OF CELLS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-07-21 | — | — | WO | disclosed |
| WO-1992005190-A1 | DEOXYHYPUSYL HYDROXYLASE INHIBITORS | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 1992-04-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260043042-A1 | Plants with Modified Deoxyhypusine Synthase Genes | DHPS, FDPS, FPGS | FOLH1 1966/4885GSR 788/4885RNPEP 1927/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.